All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves first pharmacologic treatment of ROP for preterm infants ➤ FDA accepts NDA for dilation reversal drop ➤ Phase 2b results for anti-VEGF agent for wet AMD ➤ Interim results for Phase 1 study evaluating hydrogel implant for retinal diseases ➤ Data from ongoing Phase 1/2 clinical trial of gene therapy for Leber congenital amaurosis ➤ ASCRS news and events
➤ Alert: eye infections linked to artificial tear ➤ Phase 2 data from research targeting Sjogren’s treatment ➤ First patient dosed in Phase 1 study for epithelial defect treatment ➤ Study compares DMEK tissue preparation techniques ➤ Topline results from oral diabetic retinopathy treatment trial ➤ ASCRS news and events
➤ Clinical trial for new cataract surgery technology ➤ Topline results from Phase 2 trial investigating treatment for persistent corneal epithelial defect ➤ Update on sustained-release glaucoma implant and Glaukos cornea programs ➤ First patient enrolled in Phase 3 trial for presbyopia drop ➤ ASCRS news and events
➤ FDA approves NDA for IOP-lowering drug ➤ NDA submitted for presbyopia drop ➤ IND accepted for investigational treatment of persistent corneal epithelial defect ➤ Topline results from Phase 2 study of novel sedation drug for cataract surgery ➤ First patient enrolled in Phase 3 trial for investigational TED therapy ➤ Complimentary access to video journal ➤ ASCRS news and events
The use of NSAIDs in the context of cataract surgery remains a hot topic among surgeons. EyeWorld spoke with two ophthalmologists to hear their current perspectives on NSAID use in cataract surgery.
Four surgeons discussed the importance of ergonomics in ophthalmology, including their personal experiences and how they arrange their clinics and ORs for better ergonomics.
➤ NDA submitted for new, topical dry eye disease treatment ➤ IND submitted for persistent corneal epithelial defect treatment ➤ IND filed for dry eye disease treatment ➤ Study: Investigational topical drop reduces inflammation in anterior uveitis cases ➤ Alcon completes acquisition of Aerie ➤ ASCRS news and events
Ever since Shin Yamane, MD, PhD, introduced flanged intrascleral haptic fixation with a double-needle technique, surgeons have been refining and building upon this technique. A recent paper adds to the body of research on the flanged method of intrascleral haptic fixation, with Kronschläger et al. describing how to “[attain] optimal flange size with 5-0 and 6-0 polypropylene sutures for scleral fixation.”
➤ FDA approves AI-based diabetic retinopathy screener ➤ FDA accepts NDA for Demodex treatment ➤ Phase 2b results for MGD therapy ➤ Phase 1/2 trial evaluates investigational TED treatment ➤ Phase 1 clinical trial to study synthetic cannabinoid derivative for glaucoma ➤ OCT company rebrands ➤ ASCRS news and events
➤ CDC reports cases of ocular monkeypox ➤ Recall of intravitreal implant ➤ NDA filed for nanoemulsion for postop inflammation and pain ➤ Companies partner to enhance visual assessment technology ➤ Companies enter into business combination agreement ➤ ASCRS news and events